Cite
HARVARD Citation
Ferraro, D. et al. (2018). First-line disease-modifying drugs in relapsing–remitting multiple sclerosis: an Italian real-life multicenter study on persistence. Current medical research and opinion. pp. 1803-1807. [Online].